Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsGoodwillGoodwill & IntangiblesInterest DepositsInventoryLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - AffiliatesReceivables - CustomersRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableSecurities BorrowedSecurities BoughtShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nomura Holdings (NMR) Securities - Mortgage Backed Securities (2016 - 2025)

Nomura Holdings has reported Securities - Mortgage Backed Securities over the past 17 years, most recently at $24.8 billion for Q4 2025.

  • For Q4 2025, Securities - Mortgage Backed Securities rose 2.54% year-over-year to $24.8 billion; the TTM value through Dec 2025 reached $24.8 billion, up 2.54%, while the annual FY2014 figure was $22.4 billion, 11.02% down from the prior year.
  • Securities - Mortgage Backed Securities for Q4 2025 was $24.8 billion at Nomura Holdings, up from $24.5 billion in the prior quarter.
  • Over five years, Securities - Mortgage Backed Securities peaked at $25.6 billion in Q2 2021 and troughed at $22.6 billion in Q4 2022.
  • A 5-year average of $24.1 billion and a median of $24.2 billion in 2024 define the central range for Securities - Mortgage Backed Securities.
  • Biggest five-year swings in Securities - Mortgage Backed Securities: fell 10.58% in 2022 and later increased 8.36% in 2025.
  • Year by year, Securities - Mortgage Backed Securities stood at $25.3 billion in 2021, then fell by 10.58% to $22.6 billion in 2022, then grew by 0.38% to $22.7 billion in 2023, then rose by 6.33% to $24.2 billion in 2024, then grew by 2.54% to $24.8 billion in 2025.
  • Business Quant data shows Securities - Mortgage Backed Securities for NMR at $24.8 billion in Q4 2025, $24.5 billion in Q3 2025, and $24.8 billion in Q2 2025.